Page last updated: 2024-11-04

rofecoxib and Gynecomastia

rofecoxib has been researched along with Gynecomastia in 1 studies

Gynecomastia: Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martínez, JA1
Tejada González, P1
Gutiérrez Sanpedro, N1
González Blanco, P1

Other Studies

1 other study available for rofecoxib and Gynecomastia

ArticleYear
[Gynecomastia secondary to rofecoxib].
    Medicina clinica, 2002, Jun-01, Volume: 118, Issue:20

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Gynecomastia; Humans; Lactones;

2002